Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)
- Author
- MAGGIONI, Aldo P1 ; LATINI, Roberto2 ; CARSON, Peter E3 ; SINGH, Steven N3 ; BARLERA, Simona2 ; GLAZER, Robert4 ; MASSON, Serge2 ; CERE, Elisabetta5 ; TOGNONI, Gianni2 ; COHN, Jay N6
[1] ANMCO Research Center, Florence, Italy
[2] Mario Negri Institute, Milan, Italy
[3] Department of Cardiology, Veterans Administration Medical Centers, Washington, DC, United States
[4] Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
[5] Department of Cardiology, Bentivoglio Hospital, Bologna, Italy
[6] University of Minnesota, Minneapolis, Minn, United States - Source
The American heart journal. 2005, Vol 149, Num 3, pp 548-557, 10 p ; ref : 32 ref
- CODEN
- AHJOA2
- ISSN
- 0002-8703
- Scientific domain
- Cardiology, blood circulation, phlebology
- Publisher
- Elsevier, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Appareil circulatoire pathologie Cardiopathie Fibrillation auriculaire Homme Incidence Insuffisance cardiaque Résultat Valsartan Epidémiologie Trouble excitabilité Trouble rythme cardiaque
- Keyword (en)
- Cardiovascular disease Heart disease Atrial fibrillation Human Incidence Heart failure Result Valsartan Epidemiology Excitability disorder Arrhythmia
- Keyword (es)
- Aparato circulatorio patología Cardiopatía Fibrilación auricular Hombre Incidencia Insuficiencia cardíaca Resultado Valsartán Epidemiología Trastorno excitabilidad Arritmia
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A01 Heart failure, cardiogenic pulmonary edema, cardiac enlargement
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A02 Cardiac dysrhythmias
- Discipline
- Cardiology. Circulatory system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 16739779
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.ahj.2004.09.033 
https://dx.doi.org/10.1016/j.ahj.2004.09.033
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.ahj.2004.09.033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)\";s:9:\"\u0000*\u0000jtitle\";s:26:\"The American heart journal\";s:9:\"\u0000*\u0000stitle\";s:11:\"Am. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"149\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"548\";s:8:\"\u0000*\u0000epage\";s:3:\"557\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-8703\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MAGGIONI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Aldo P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"LATINI, Roberto\";i:1;s:15:\"CARSON, Peter E\";i:2;s:15:\"SINGH, Steven N\";i:3;s:15:\"BARLERA, Simona\";i:4;s:14:\"GLAZER, Robert\";i:5;s:13:\"MASSON, Serge\";i:6;s:16:\"CERE, Elisabetta\";i:7;s:15:\"TOGNONI, Gianni\";i:8;s:11:\"COHN, Jay N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AHJOA2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.ahj.2004.09.033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)\";s:9:\"\u0000*\u0000jtitle\";s:26:\"The American heart journal\";s:9:\"\u0000*\u0000stitle\";s:11:\"Am. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"149\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"548\";s:8:\"\u0000*\u0000epage\";s:3:\"557\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-8703\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MAGGIONI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Aldo P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"LATINI, Roberto\";i:1;s:15:\"CARSON, Peter E\";i:2;s:15:\"SINGH, Steven N\";i:3;s:15:\"BARLERA, Simona\";i:4;s:14:\"GLAZER, Robert\";i:5;s:13:\"MASSON, Serge\";i:6;s:16:\"CERE, Elisabetta\";i:7;s:15:\"TOGNONI, Gianni\";i:8;s:11:\"COHN, Jay N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AHJOA2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.ahj.2004.09.033\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.ahj.2004.09.033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)\";s:9:\"\u0000*\u0000jtitle\";s:26:\"The American heart journal\";s:9:\"\u0000*\u0000stitle\";s:11:\"Am. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"149\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"548\";s:8:\"\u0000*\u0000epage\";s:3:\"557\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-8703\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MAGGIONI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Aldo P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"LATINI, Roberto\";i:1;s:15:\"CARSON, Peter E\";i:2;s:15:\"SINGH, Steven N\";i:3;s:15:\"BARLERA, Simona\";i:4;s:14:\"GLAZER, Robert\";i:5;s:13:\"MASSON, Serge\";i:6;s:16:\"CERE, Elisabetta\";i:7;s:15:\"TOGNONI, Gianni\";i:8;s:11:\"COHN, Jay N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AHJOA2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.ahj.2004.09.033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)\";s:9:\"\u0000*\u0000jtitle\";s:26:\"The American heart journal\";s:9:\"\u0000*\u0000stitle\";s:11:\"Am. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"149\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"548\";s:8:\"\u0000*\u0000epage\";s:3:\"557\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-8703\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MAGGIONI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Aldo P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"LATINI, Roberto\";i:1;s:15:\"CARSON, Peter E\";i:2;s:15:\"SINGH, Steven N\";i:3;s:15:\"BARLERA, Simona\";i:4;s:14:\"GLAZER, Robert\";i:5;s:13:\"MASSON, Serge\";i:6;s:16:\"CERE, Elisabetta\";i:7;s:15:\"TOGNONI, Gianni\";i:8;s:11:\"COHN, Jay N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AHJOA2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.ahj.2004.09.033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)\";s:9:\"\u0000*\u0000jtitle\";s:26:\"The American heart journal\";s:9:\"\u0000*\u0000stitle\";s:11:\"Am. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:3:\"149\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"548\";s:8:\"\u0000*\u0000epage\";s:3:\"557\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-8703\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"MAGGIONI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Aldo P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"LATINI, Roberto\";i:1;s:15:\"CARSON, Peter E\";i:2;s:15:\"SINGH, Steven N\";i:3;s:15:\"BARLERA, Simona\";i:4;s:14:\"GLAZER, Robert\";i:5;s:13:\"MASSON, Serge\";i:6;s:16:\"CERE, Elisabetta\";i:7;s:15:\"TOGNONI, Gianni\";i:8;s:11:\"COHN, Jay N\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AHJOA2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
